Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

ALS is the most common form of motor neurone disease (MND)

ALS is a fatal neurodegenerative disorder. It is characterized by progressive muscular paralysis reflecting the degeneration of motor neurons in the primary motor cortex, corticospinal tracts, brainstem and spinal cord.

Up to 5000

Adults in the UK are affected by MND at any one time

Source: MND Association, 2025
55 years

Average age of onset of ALS

Source: ALS Association, 2025
1 in 300

Risk of developing MND across a lifetime

Source: MND Association, 2025
ALS

Zambon is committed to providing treatment options in CNS

Through its collaboration with Aquestive, Zambon has further strengthened its commitment to orphan diseases and to the CNS area, enriching its portfolio with a therapy for ALS.